Enhancing cell therapy manufacturing: Flexible solutions for CAR T production
- Introducing a rapid 18-hour process for autologous CAR-T therapy using Lupus patient material
- Demonstrates potent cytotoxicity and expansion potential of the cryopreserved cells
- Explore flexible options for every workflow